POZ Community Forums
Main Forums => AIDS Activism => Topic started by: Jim Allen on February 10, 2020, 03:57:40 pm
-
https://www.poz.com/article/gilead-loses-latest-battle-prep-patents-fight-goes
A federal panel refused a request by pharmaceutical company Gilead Sciences to invalidate a pair of patents owned by the federal government to use Truvada as PrEP, or pre-exposure prophylaxis, to prevent HIV.
As STAT News reports, the ruling from the Patent Trial and Appeals Board is a setback for Gilead but other challenges and rulings remain in the ongoing legal battle over PrEP.
Last year, the Department of Health and Human Services (HHS) sued Gilead, saying the drugmaker infringed on the government’s patents on a pair of meds. Basically, the federal government and the pharma company are battling over the rights to the discovery that HIV treatment can also be used as HIV prevention.